Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule.

Sauzay C, Voutetakis K, Chatziioannou A, Chevet E, Avril T.

Front Cell Dev Biol. 2019 Apr 26;7:66. doi: 10.3389/fcell.2019.00066. eCollection 2019. Review.

2.

Emerging Roles of the Endoplasmic Reticulum Associated Unfolded Protein Response in Cancer Cell Migration and Invasion.

Limia CM, Sauzay C, Urra H, Hetz C, Chevet E, Avril T.

Cancers (Basel). 2019 May 6;11(5). pii: E631. doi: 10.3390/cancers11050631. Review.

3.

Early decrease in serum amphiregulin or vascular endothelial growth factor levels predicts sorafenib efficacy in hepatocellular carcinoma.

Godin C, Bodeau S, Saidak Z, Louandre C, François C, Barbare JC, Coriat R, Galmiche A, Sauzay C.

Oncol Rep. 2019 Mar;41(3):2041-2050. doi: 10.3892/or.2018.6922. Epub 2018 Dec 10.

PMID:
30569112
4.

A pan-cancer study of the transcriptional regulation of uricogenesis in human tumours: pathological and pharmacological correlates.

Saidak Z, Louandre C, Dahmani S, Sauzay C, Guedda S, Chauffert B, Chatelain D, Ceballos-Picot I, Galmiche A.

Biosci Rep. 2018 Sep 19;38(5). pii: BSR20171716. doi: 10.1042/BSR20171716. Print 2018 Oct 31.

5.

Protein biosynthesis, a target of sorafenib, interferes with the unfolded protein response (UPR) and ferroptosis in hepatocellular carcinoma cells.

Sauzay C, Louandre C, Bodeau S, Anglade F, Godin C, Saidak Z, Fontaine JX, Usureau C, Martin N, Molinie R, Pascal J, Mesnard F, Pluquet O, Galmiche A.

Oncotarget. 2018 Jan 3;9(9):8400-8414. doi: 10.18632/oncotarget.23843. eCollection 2018 Feb 2.

6.

Squamous Cell Carcinoma Antigen-encoding Genes SERPINB3/B4 as Potentially Useful Markers for the Stratification of HNSCC Tumours.

Saidak Z, Morisse MC, Chatelain D, Sauzay C, Houessinon A, Guilain N, Soyez M, Chauffert B, Dakpé S, Galmiche A.

Anticancer Res. 2018 Mar;38(3):1343-1352.

PMID:
29491058
7.

A potential role of the unfolded protein response in post-transplant cancer.

Bodeau S, Sauzay C, Pluquet O, Choukroun G, Galmiche A.

Clin Sci (Lond). 2017 Jun 22;131(13):1429-1436. doi: 10.1042/CS20170152. Print 2017 Jul 1. Review.

PMID:
28645931
8.

Targeting the Unfolded Protein Response as a Potential Therapeutic Strategy in Renal Carcinoma Cells Exposed to Cyclosporine A.

Bodeau S, Sauzay C, Nyga R, Louandre C, Descamps V, François C, Godin C, Choukroun G, Galmiche A.

Anticancer Res. 2017 Mar;37(3):1049-1057.

PMID:
28314264
9.

Mathematical modelling unveils the essential role of cellular phosphatases in the inhibition of RAF-MEK-ERK signalling by sorafenib in hepatocellular carcinoma cells.

Saidak Z, Giacobbi AS, Louandre C, Sauzay C, Mammeri Y, Galmiche A.

Cancer Lett. 2017 Apr 28;392:1-8. doi: 10.1016/j.canlet.2017.01.038. Epub 2017 Feb 2.

PMID:
28161506
10.

Role of the unfolded protein response in tumor cell characteristics and cancer outcome.

Galmiche A, Sauzay C, Chevet E, Pluquet O.

Curr Opin Oncol. 2017 Jan;29(1):41-47. Review.

PMID:
27845970
11.

Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma.

Sauzay C, Petit A, Bourgeois AM, Barbare JC, Chauffert B, Galmiche A, Houessinon A.

Clin Chim Acta. 2016 Dec 1;463:39-44. doi: 10.1016/j.cca.2016.10.006. Epub 2016 Oct 11. Review.

PMID:
27732875
12.

Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.

Houessinon A, François C, Sauzay C, Louandre C, Mongelard G, Godin C, Bodeau S, Takahashi S, Saidak Z, Gutierrez L, Régimbeau JM, Barget N, Barbare JC, Ganne N, Chauffert B, Coriat R, Galmiche A.

Mol Cancer. 2016 May 16;15(1):38. doi: 10.1186/s12943-016-0526-2.

13.

Probing Tumour Proteostasis and the UPR with Serum Markers.

Galmiche A, Sauzay C, Houessinon A, Chauffert B, Pluquet O.

Trends Cancer. 2016 May;2(5):219-221. doi: 10.1016/j.trecan.2016.04.004. Epub 2016 Apr 28.

PMID:
28741509
14.

Development and validation of a rapid and simple LC-MS/MS method for quantification of vemurafenib in human plasma: application to a human pharmacokinetic study.

Bihan K, Sauzay C, Goldwirt L, Charbonnier-Beaupel F, Hulot JS, Funck-Brentano C, Zahr N.

Ther Drug Monit. 2015 Feb;37(1):132-6. doi: 10.1097/FTD.0000000000000110.

PMID:
24977381

Supplemental Content

Loading ...
Support Center